{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T03:11:06Z","timestamp":1773889866393,"version":"3.50.1"},"reference-count":102,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","amjmedsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.amjms.2017.03.020","type":"journal-article","created":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T18:46:56Z","timestamp":1489603616000},"page":"339-349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Eosinophilic Lung Disease"],"prefix":"10.1016","volume":"354","author":[{"given":"Jonathan C.","family":"Weissler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.amjms.2017.03.020_bib1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s12016-015-8526-3","article-title":"The role and immunobiology of eosinophils in the respiratory system: a comprehensive review","volume":"50","author":"Eng","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"10.1016\/j.amjms.2017.03.020_bib2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaci.2012.02.019","article-title":"Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes","volume":"130","author":"Valent","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.amjms.2017.03.020_bib3","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2010.04.004","article-title":"MEDI-563, a humanized anti\u2013IL-5 receptor \u03b1 mAb with enhanced antibody-dependent cell-mediated cytotoxicity function","volume":"125","author":"Kolbeck","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.amjms.2017.03.020_bib4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000445215","article-title":"A player and coordinator: the versatile roles of eosinophils in the immune system","volume":"43","author":"Long","year":"2016","journal-title":"Transfus Med Hemother"},{"issue":"7","key":"10.1016\/j.amjms.2017.03.020_bib5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/intimm\/dxr029","article-title":"An updated view on transcription factor GATA3-mediated regulation of Th1 and Th2 cell differentiation","volume":"23","author":"Yagi","year":"2011","journal-title":"Int Immunol"},{"issue":"1","key":"10.1016\/j.amjms.2017.03.020_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2567.2012.03556.x","article-title":"Pattern-recognition receptors in human eosinophils","volume":"136","author":"Kvarnhammar","year":"2012","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.amjms.2017.03.020_bib7","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1084\/jem.20071836","article-title":"Strain-specific requirement for eosinophils in the recruitment of T cells to the lung during the development of allergic asthma","volume":"205","author":"Walsh","year":"2008","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.amjms.2017.03.020_bib8","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.immuni.2014.02.014","article-title":"Eosinophils promote generation and maintenance of immunoglobulin-A-expressing plasma cells and contribute to gut immune homeostasis","volume":"40","author":"Chu Van","year":"2014","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.amjms.2017.03.020_bib9","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1136\/gutjnl-2014-306998","article-title":"Eosinophil-mediated signalling attenuates inflammatory responses in experimental colitis","volume":"64","author":"Masterson","year":"2015","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.amjms.2017.03.020_bib10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1096\/fj.10-170027","article-title":"Eosinophils promote resolution of acute peritonitis by producing proresolving mediators in mice","volume":"25","author":"Yamada","year":"2011","journal-title":"FASEB J"},{"issue":"12","key":"10.1016\/j.amjms.2017.03.020_bib11","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.1182\/blood-2002-10-3058","article-title":"Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis","volume":"101","author":"Nutku","year":"2003","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.amjms.2017.03.020_bib12","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3109\/02770903.2012.713428","article-title":"Is a single blood eosinophil count a reliable marker for \u201cEosinophilic Asthma?\u201d","volume":"49","author":"Spector","year":"2012","journal-title":"J Asthma"},{"issue":"7","key":"10.1016\/j.amjms.2017.03.020_bib13","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3109\/00365513.2011.602422","article-title":"Diurnal variation of hematology parameters in healthy young males: the Bispebjerg study of diurnal variations","volume":"71","author":"Sennels","year":"2011","journal-title":"Scand J Clin Lab Invest"},{"issue":"1","key":"10.1016\/j.amjms.2017.03.020_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jaci.2010.04.011","article-title":"Practical approach to the patient with hypereosinophilia","volume":"126","author":"Roufosse","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.amjms.2017.03.020_bib15","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.4049\/jimmunol.163.11.6321","article-title":"Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (intrinsic) asthmatics","volume":"163","author":"Ying","year":"1999","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.amjms.2017.03.020_bib16","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0091-6749(99)70069-2","article-title":"Molecular basis for selective eosinophil trafficking in asthma: a multistep paradigm","volume":"104","author":"Wardlaw","year":"1999","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.amjms.2017.03.020_bib17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.iac.2015.05.002","article-title":"Eosinophilia in pulmonary disorders","volume":"35","author":"Woolnough","year":"2015","journal-title":"Immunol Allergy Clin North Am"},{"issue":"10","key":"10.1016\/j.amjms.2017.03.020_bib18","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood.V95.10.3146","article-title":"Interleukin-13 induces PSGL-1\/P-selectin-dependent adhesion of eosinophils, but not neutrophils, to human umbilical vein endothelial cells under flow","volume":"95","author":"Woltmann","year":"2000","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.amjms.2017.03.020_bib19","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/cea.12244","article-title":"Safety and efficacy of an oral CCR3 antagonist in patients with asthma and eosinophilic bronchitis: a randomized, placebo-controlled clinical trial","volume":"44","author":"Neighbour","year":"2014","journal-title":"Clin Exp Allergy"},{"issue":"7","key":"10.1016\/j.amjms.2017.03.020_bib20","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1182\/blood.V98.7.2239","article-title":"Interleukin-5 inhibits translocation of Bax to the mitochondria, cytochrome c release, and activation of caspases in human eosinophils","volume":"98","author":"Dewson","year":"2001","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.amjms.2017.03.020_bib21","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.4049\/jimmunol.170.11.5359","article-title":"Differential regulation of human eosinophil IL-3, IL-5, and GM-CSF receptor \u03b1-chain expression by cytokines: IL-3, IL-5, and GM-CSF down-regulate IL-5 receptor \u03b1 expression with loss of IL-5 responsiveness, but up-regulate IL-3 receptor \u03b1 expression","volume":"170","author":"Gregory","year":"2003","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.amjms.2017.03.020_bib22","doi-asserted-by":"crossref","first-page":"8354","DOI":"10.4049\/jimmunol.180.12.8354","article-title":"CCL11 and GM-CSF differentially use the rho GTPase pathway to regulate motility of human eosinophils in a three-dimensional microenvironment","volume":"180","author":"Muessel","year":"2008","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.amjms.2017.03.020_bib23","first-page":"473","article-title":"Pulmonary macrophages: Functional comparison of cells in whole lung and bronchoalveolar lavage","volume":"133","author":"Weissler","year":"1986","journal-title":"Am Rev Respir Dis"},{"issue":"4","key":"10.1016\/j.amjms.2017.03.020_bib24","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1164\/arrd.1987.135.4.941","article-title":"Natural killer cell function in human lung is compartmentalized","volume":"135","author":"Weissler","year":"1987","journal-title":"Am Rev Respir Dis"},{"issue":"6","key":"10.1016\/j.amjms.2017.03.020_bib25","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1378\/chest.11-0627","article-title":"Counterpoint: is measuring sputum eosinophils useful in the management of severe asthma? no, not for the vast majority of patients","volume":"139","author":"Peters","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.amjms.2017.03.020_bib26","first-page":"1270","article-title":"Point: is measuring sputum eosinophils useful in the management of severe asthma? yes","volume":"139","author":"Hargreave","year":"2011"},{"issue":"4","key":"10.1016\/j.amjms.2017.03.020_bib27","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S2213-2600(15)00050-8","article-title":"Diagnostic accuracy of minimally invasive markers for detection of airway eosinophilia in asthma: a systematic review and meta-analysis","volume":"3","author":"Korevaar","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.amjms.2017.03.020_bib28","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jaci.2012.06.025","article-title":"Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients","volume":"130","author":"Jia","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"24","key":"10.1016\/j.amjms.2017.03.020_bib29","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1001\/jama.292.24.2997","article-title":"Acute eosinophilic pneumonia among us military personnel deployed in or near iraq","volume":"292","author":"Shorr","year":"2004","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.amjms.2017.03.020_bib30","series-title":"Orphan Lung Diseases: A Clinical Guide to Rare Lung Disease","first-page":"227","article-title":"Eosinophilic pneumonia","author":"Cottin","year":"2015"},{"issue":"3","key":"10.1016\/j.amjms.2017.03.020_bib31","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.iac.2007.07.005","article-title":"Pulmonary eosinophilic syndromes","volume":"27","author":"Wechsler","year":"2007","journal-title":"Immunol Allergy Clin North Am"},{"issue":"3","key":"10.1016\/j.amjms.2017.03.020_bib32","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaci.2012.02.019","article-title":"Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes","volume":"130","author":"Valent","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.amjms.2017.03.020_bib33","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ccm.2016.04.015","article-title":"Eosinophilic lung diseases","volume":"37","author":"Cottin","year":"2016","journal-title":"Clin Chest Med"},{"issue":"3","key":"10.1016\/j.amjms.2017.03.020_bib34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/thx.2010.135574","article-title":"A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils)","volume":"67","author":"Petsky","year":"2012","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.amjms.2017.03.020_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.anai.2014.04.011","article-title":"High blood eosinophil count is associated with more frequent asthma attacks in asthma patients","volume":"113","author":"Tran","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.amjms.2017.03.020_bib37","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.pupt.2013.07.003","article-title":"Complex phenotypes in asthma: current definitions","volume":"26","author":"Wenzel","year":"2013","journal-title":"Pulm Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.amjms.2017.03.020_bib38","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1164\/ajrccm.160.3.9812110","article-title":"Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics","volume":"160","author":"Wenzel","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.amjms.2017.03.020_bib39","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/all.12465","article-title":"Vitamin D deficiency induces Th2 skewing and eosinophilia in neonatal allergic airways disease","volume":"69","author":"Vasiliou","year":"2014","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.amjms.2017.03.020_bib40","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaci.2014.11.033","article-title":"Vitamin D reduces eosinophilic airway inflammation in nonatopic asthma","volume":"135","author":"de Groot","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.amjms.2017.03.020_bib41","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1164\/rccm.201109-1640OC","article-title":"A large subgroup of mild-to-moderate asthma is persistently noneosinophilic","volume":"185","author":"McGrath","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.amjms.2017.03.020_bib42","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.molcel.2005.03.025","article-title":"Translational regulatory mechanisms generate n-terminal glucocorticoid receptor isoforms with unique transcriptional target genes","volume":"18","author":"Lu","year":"2005","journal-title":"Mol Cell"},{"issue":"5","key":"10.1016\/j.amjms.2017.03.020_bib43","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jaci.2013.09.007","article-title":"The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease","volume":"132","author":"Oakley","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.amjms.2017.03.020_bib44","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1164\/rccm.200507-1046OC","article-title":"Increased glucocorticoid receptor \u03b2 alters steroid response in glucocorticoid-insensitive asthma","volume":"173","author":"Goleva","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.amjms.2017.03.020_bib45","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/j.1365-2222.2010.03544.x","article-title":"Induction of glucocorticoid receptor-\u03b2 expression in epithelial cells of asthmatic airways by T-helper type 17 cytokines","volume":"40","author":"Vazquez-Tello","year":"2010","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.amjms.2017.03.020_bib46","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1067\/mai.2000.109054","article-title":"Increased number of glucocorticoid receptor-\u03b2\u2013expressing cells in the airways in fatal asthma","volume":"106","author":"Christodoulopoulos","year":"2000","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.amjms.2017.03.020_bib47","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2013.04.012","article-title":"IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma","volume":"132","author":"Saglani","year":"2013","journal-title":"J Allergy Clin Immunology"},{"issue":"2","key":"10.1016\/j.amjms.2017.03.020_bib48","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1183\/09031936.00017911","article-title":"Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells","volume":"39","author":"Zijlstra","year":"2012","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.amjms.2017.03.020_bib51","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1164\/rccm.200206-525OC","article-title":"Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma","volume":"167","author":"Kips","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.amjms.2017.03.020_bib52","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1164\/rccm.200701-085OC","article-title":"A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma","volume":"176","author":"Flood-Page","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"13","key":"10.1016\/j.amjms.2017.03.020_bib54","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.amjms.2017.03.020_bib55","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S2213-2600(16)30031-5","article-title":"Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies","volume":"4","author":"Ortega","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.amjms.2017.03.020_bib56","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1164\/rccm.200208-789OC","article-title":"Eosinophil\u2019s role remains uncertain as anti\u2013interleukin-5 only partially depletes numbers in asthmatic airway","volume":"167","author":"Flood-Page","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.amjms.2017.03.020_bib57","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMoa0808991","article-title":"Mepolizumab and exacerbations of refractory eosinophilic asthma","volume":"360","author":"Haldar","year":"2009","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.amjms.2017.03.020_bib58","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S2213-2600(15)00042-9","article-title":"Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials","volume":"3","author":"Castro","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"10","key":"10.1016\/j.amjms.2017.03.020_bib59","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1164\/rccm.201103-0396OC","article-title":"Reslizumab for poorly controlled, eosinophilic asthma","volume":"184","author":"Castro","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.amjms.2017.03.020_bib60","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.chest.2016.03.018","article-title":"Phase 3 study of reslizumab in patients with poorly controlled asthma: effects across a broad range of eosinophil counts","volume":"150","author":"Corren","year":"2016","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.amjms.2017.03.020_bib61","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jaci.2013.05.020","article-title":"Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia","volume":"132","author":"Laviolette","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.amjms.2017.03.020_bib62","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2010.04.004","article-title":"MEDI-563, a humanized anti-interleukin-5 receptor-alpha monoclonal antibody with enhanced antibody-dependent cell-mediated cytotoxicity function","volume":"125","author":"Kolbeck","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"10056","key":"10.1016\/j.amjms.2017.03.020_bib63","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","article-title":"Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting \u03b22-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial","volume":"388","author":"Bleecker","year":"2016","journal-title":"Lancet"},{"issue":"10056","key":"10.1016\/j.amjms.2017.03.020_bib64","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(16)31322-8","article-title":"Benralizumab, an anti-interleukin-5 receptor \u03b1 monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"388","author":"FitzGerald","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.amjms.2017.03.020_bib65","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/WOX.0b013e31821188e0","article-title":"Interleukin-13 signaling and its role in asthma","volume":"4","author":"Rael","year":"2011","journal-title":"World Allergy Organ J"},{"issue":"26","key":"10.1016\/j.amjms.2017.03.020_bib66","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1304048","article-title":"Dupilumab in persistent asthma with elevated eosinophil levels","volume":"368","author":"Wenzel","year":"2013","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.amjms.2017.03.020_bib67","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1056\/NEJMoa1106469","article-title":"Lebrikizumab treatment in adults with asthma","volume":"365","author":"Corren","year":"2011","journal-title":"N Engl J Med"},{"issue":"10039","key":"10.1016\/j.amjms.2017.03.020_bib68","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(16)30307-5","article-title":"Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting \u03b22 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial","volume":"388","author":"Wenzel","year":"2016","journal-title":"Lancet"},{"issue":"suppl 3","key":"10.1016\/j.amjms.2017.03.020_bib69","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1086\/376525","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis\u2014state of the art: cystic fibrosis foundation consensus conference","volume":"37","author":"Stevens","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.amjms.2017.03.020_bib70","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1067\/mai.2002.130179","article-title":"Allergic bronchopulmonary aspergillosis","volume":"110","author":"Greenberger","year":"2002","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.amjms.2017.03.020_bib71","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1378\/chest.08-2586","article-title":"Allergic bronchopulmonary aspergillosis","volume":"135","author":"Agarwal","year":"2009","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.amjms.2017.03.020_bib72","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1172\/JCI118675","article-title":"T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis","volume":"97","author":"Chauhan","year":"1996","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.amjms.2017.03.020_bib73","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/cea.12141","article-title":"Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria","volume":"43","author":"Agarwal","year":"2013","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.amjms.2017.03.020_bib74","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1378\/chest.130.2.442","article-title":"Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in North India","volume":"130","author":"Agarwal","year":"2006","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.amjms.2017.03.020_bib75","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaci.2011.12.970","article-title":"Fungi and allergic lower respiratory tract diseases","volume":"129","author":"Knutsen","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.amjms.2017.03.020_bib76","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.amjms.2017.03.020_bib77","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJM200003163421102","article-title":"A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis","volume":"342","author":"Stevens","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2017.03.020_bib78","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.rmed.2016.11.019","article-title":"Beneficial effects of omalizumab therapy in allergic bronchopulmonary aspergillosis: a synthesis review of published literature","volume":"122","author":"Li","year":"2017","journal-title":"Respir Med"},{"issue":"2","key":"10.1016\/j.amjms.2017.03.020_bib79","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jaip.2014.12.008","article-title":"Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis","volume":"3","author":"Voskamp","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.amjms.2017.03.020_bib80","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000023928","article-title":"Predominant implication of IL-5 in acute eosinophilic pneumonia: comparison with chronic eosinophilic pneumonia","volume":"116","author":"Okubo","year":"1998","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"10.1016\/j.amjms.2017.03.020_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2214\/ajr.128.1.1","article-title":"Peripheral opacities in chronic eosinophilic pneumonia: the photographic negative of pulmonary edema","volume":"128","author":"Gaensler","year":"1977","journal-title":"Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.amjms.2017.03.020_bib82","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.rcl.2016.05.008","article-title":"Imaging of eosinophilic lung diseases","volume":"54","author":"Price","year":"2016","journal-title":"Radiologic Clin North Am"},{"issue":"6","key":"10.1016\/j.amjms.2017.03.020_bib83","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1164\/rccm.200206-576OC","article-title":"Acute eosinophilic pneumonia in a New York City firefighter exposed to World Trade Center Dust","volume":"166","author":"Rom","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.amjms.2017.03.020_bib84","first-page":"31","article-title":"Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome","volume":"6","author":"Choudhary","year":"2013","journal-title":"The Journal of Clinical and Aesthetic Dermatology"},{"issue":"2","key":"10.1016\/j.amjms.2017.03.020_bib85","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1365-2133.2006.07284.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"155","author":"Peyri\u00e8re","year":"2006","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.amjms.2017.03.020_bib86","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0761-8425(07)91393-5","article-title":"Severe drug rash with eosinophilia and systemic symptoms after treatment with minocycline","volume":"24","author":"Favrolt","year":"2007","journal-title":"Rev Mal Respir"},{"issue":"1","key":"10.1016\/j.amjms.2017.03.020_bib87","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0033-8389(03)00109-X","article-title":"High-resolution CT of drug-induced lung disease","volume":"40","author":"Erasmus","year":"2002","journal-title":"Radiologic Clin North Am"},{"issue":"5","key":"10.1016\/j.amjms.2017.03.020_bib88","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00005792-199309000-00001","article-title":"Toxic oil syndrome: a long-term follow-up of a cohort of 332 patients","volume":"72","author":"Alonso-Ruiz","year":"1993","journal-title":"Medicine"},{"issue":"13","key":"10.1016\/j.amjms.2017.03.020_bib89","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1001\/jama.1990.03450130070029","article-title":"Eosinophilia-myalgia syndrome: results of national surveillance","volume":"264","author":"Swygert","year":"1990","journal-title":"J Am Med Assoc"},{"issue":"5","key":"10.1016\/j.amjms.2017.03.020_bib90","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1378\/chest.105.5.1599","article-title":"L\u00f6ffler\u2019s syndrome secondary to crack cocaine","volume":"105","author":"Nadeem","year":"1994","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.amjms.2017.03.020_bib91","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1378\/chest.105.4.1261","article-title":"Eosinophilic lung reaction to aluminium and hard metal","volume":"105","author":"Schwarz","year":"1994","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.amjms.2017.03.020_bib92","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1378\/chest.95.3.691","article-title":"Pulmonary infiltration with blood eosinophilia after scorpion sting","volume":"95","author":"Shah","year":"1989","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.amjms.2017.03.020_bib93","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/pim.12102","article-title":"Helminths in the lungs","volume":"36","author":"Craig","year":"2014","journal-title":"Parasite Immunol"},{"issue":"5","key":"10.1016\/j.amjms.2017.03.020_bib94","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/MCP.0b013e3281eb8ec9","article-title":"Tropical pulmonary eosinophilia: pathogenesis, diagnosis and management","volume":"13","author":"Vijayan","year":"2007","journal-title":"Curr Opin Pulm Med"},{"issue":"8","key":"10.1016\/j.amjms.2017.03.020_bib95","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1086\/423964","article-title":"Tropical pulmonary eosinophilia: a case series in a setting of nonendemicity","volume":"39","author":"Boggild","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"549","key":"10.1016\/j.amjms.2017.03.020_bib96","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1259\/0007-1285-46-549-699","article-title":"Radiological findings in pulmonary paragonimiasis as seen in Nigeria: a review based on one hundred cases","volume":"46","author":"Ogakwu","year":"1973","journal-title":"Br J Radiol"},{"issue":"1024","key":"10.1016\/j.amjms.2017.03.020_bib97","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/pgmj.2010.108555","article-title":"Thoracic imaging findings in a case of disseminated cysticercosis","volume":"87","author":"Singh","year":"2011","journal-title":"Postgraduate Med J"},{"issue":"9","key":"10.1016\/j.amjms.2017.03.020_bib98","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0002-9343(00)00619-7","article-title":"Pulmonary manifestations of early schistosome infection among nonimmune travelers","volume":"109","author":"Schwartz","year":"2000","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.amjms.2017.03.020_bib100","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1182\/blood.V83.10.2759.2759","article-title":"The idiopathic hypereosinophilic syndrome","volume":"83","author":"Weller","year":"1994","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.amjms.2017.03.020_bib101","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1378\/chest.101.4.1178","article-title":"Idiopathic hypereosinophilic syndrome-related pulmonary involvement diagnosed by bronchoalveolar lavage","volume":"101","author":"Slabbynck","year":"1992","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.amjms.2017.03.020_bib102","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jaci.2009.09.022","article-title":"Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy","volume":"124","author":"Ogbogu","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.amjms.2017.03.020_bib103","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/art.1780330806","article-title":"The American College of Rheumatology 1990 criteria for the classification of Churg\u2010Strauss syndrome (allergic granulomatosis and angiitis)","volume":"33","author":"Masi","year":"1990","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.amjms.2017.03.020_bib104","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1399-3038.2005.00291.x","article-title":"Milk-induced pulmonary disease in infants (Heiner syndrome)","volume":"16","author":"Moissidis","year":"2005","journal-title":"Pediatr Allergy Immunol"},{"issue":"5","key":"10.1016\/j.amjms.2017.03.020_bib105","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.healun.2014.11.007","article-title":"Restrictive chronic lung allograft dysfunction: where are we now?","volume":"34","author":"Verleden","year":"2015","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"10.1016\/j.amjms.2017.03.020_bib106","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/TP.0b013e3182a6bae2","article-title":"Elevated bronchoalveolar lavage eosinophilia correlates with poor outcome after lung transplantation","volume":"97","author":"Verleden","year":"2014","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.amjms.2017.03.020_bib107","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.healun.2016.03.022","article-title":"Predictors of survival in restrictive chronic lung allograft dysfunction after lung transplantation","volume":"35","author":"Verleden","year":"2016","journal-title":"J Heart Lung Transplant"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962917301568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962917301568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T17:05:51Z","timestamp":1692723951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962917301568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":102,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0002962917301568"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2017.03.020","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eosinophilic Lung Disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2017.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Southern Society for Clinical Investigation. Published by All rights reserved.","name":"copyright","label":"Copyright"}]}}